SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001213900-17-000304
Filing Date
2017-01-12
Accepted
2017-01-12 17:26:35
Documents
46
Period of Report
2016-09-30

Document Format Files

Seq Description Document Type Size
1 ANNUAL REPORT f10k2016_americanbrivision.htm 10-K 716374
2 EMPLOYMENT AGREEMENT WITH KIRA HUANG f10k2016ex10iii_american.htm EX-10.3 24349
3 CERTIFICATION f10k2016ex31i_american.htm EX-31.1 6891
4 CERTIFICATION f10k2016ex31ii_american.htm EX-31.2 7689
5 CERTIFICATION f10k2016ex32i_american.htm EX-32.1 3859
6 CERTIFICATION f10k2016ex32ii_american.htm EX-32.2 4336
  Complete submission text file 0001213900-17-000304.txt   2186455

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE FILE mtoo-20160930.xml EX-101.INS 229551
8 XBRL SCHEMA FILE mtoo-20160930.xsd EX-101.SCH 24476
9 XBRL CALCULATION FILE mtoo-20160930_cal.xml EX-101.CAL 26674
10 XBRL DEFINITION FILE mtoo-20160930_def.xml EX-101.DEF 48109
11 XBRL LABEL FILE mtoo-20160930_lab.xml EX-101.LAB 171841
12 XBRL PRESENTATION FILE mtoo-20160930_pre.xml EX-101.PRE 132843
Mailing Address 11 SAWYERS PEAK DRIVE GOSHEN NY 10924
Business Address 11 SAWYERS PEAK DRIVE GOSHEN NY 10924 845-551-8728
American BriVision (Holding) Corp (Filer) CIK: 0001173313 (see all company filings)

IRS No.: 260014658 | State of Incorp.: NV | Fiscal Year End: 0930
Type: 10-K | Act: 34 | File No.: 333-91436 | Film No.: 17525995
SIC: 2834 Pharmaceutical Preparations